Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p

Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice

(2018) I. Soria et al.   ALLERGY

Long noncoding RNA LNC473 inhibits the ubiquitination of survivin via association with USP9X and enhances cell proliferation and invasion in hepatocellular carcinoma cells

(2018) Hui Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis

(2018) He-Li Gao et al.   Hepatobiliary & Pancreatic Diseases International

Long non-coding RNA lnc-PCTST predicts prognosis through inhibiting progression of pancreatic cancer by downregulation of TACC-3

(2018) Yandong Wang et al.   INTERNATIONAL JOURNAL OF CANCER

Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling

(2018) Yongping Zhou et al.   JOURNAL OF CELLULAR PHYSIOLOGY

LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer

(2018) Gang Zhang et al.   Molecular Cancer

A screen of Crohn’s disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells

(2018) Yu-Ling Chang et al.   Mucosal Immunology

Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells

(2018) Wenhao Guo et al.   PLoS One

Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC

(2018) Jie Ji et al.   Cell Death & Disease

Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine

(2018) Manendra Babu Lankadasari et al.   Theranostics

IL-35 hinders endogenous anti-tumor T cell immunity and responsiveness to immunotherapy in pancreatic cancer

(2018) Bhalchandra Mirlekar et al.   Cancer Immunology Research

MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells

(2018) Li Chai et al.   Cancer Management and Research

LINC00473 predicts poor prognosis and regulates cell migration and invasion in gastric cancer

(2018) Wei Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer

(2018) Lin Wang et al.   BIOSCIENCE REPORTS

Emerging microRNAs in cancer diagnosis, progression, and immune surveillance

(2018) Amani M. Harrandah et al.   CANCER LETTERS

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

(2018) Ming Yi et al.   Molecular Cancer

Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2

(2017) Jin Sun et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity

(2017) Sydney R. Gordon et al.   NATURE

Evaluation of fluorescence in situ hybridization techniques to study long non-coding RNA expression in cultured cells

(2017) Ricardo J Soares et al.   NUCLEIC ACIDS RESEARCH

Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells

(2017) M. Waheed Roomi et al.   ONCOLOGY REPORTS

Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis

(2017) Yongxun Zhuan-Sun et al.   OncoTargets and Therapy

PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p

(2017) Valentina Audrito et al.   Oncotarget

Metabolic Signaling Drives IFN-γ

(2016) Peter J. Siska et al.   Cell Metabolism

The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer.

(2016) Jens Geginat et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers

(2016) Keisuke Kataoka et al.   NATURE

PD-L1 expression in human cancers and its association with clinical outcomes

(2016) Jinming Yu et al.   OncoTargets and Therapy

Regulation of PD-L1: a novel role of pro-survival signalling in cancer

(2015) J. Chen et al.   ANNALS OF ONCOLOGY

Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways

(2015) Sercan Ergun et al.   TUMOR BIOLOGY

lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6

(2014) Gabriel Eades et al.   MOLECULAR CANCER RESEARCH

MicroRNA-33a Mediates the Regulation of High Mobility Group AT-Hook 2 Gene (HMGA2) by Thyroid Transcription Factor 1 (TTF-1/NKX2–1)

(2013) Shawn J. Rice et al.   JOURNAL OF BIOLOGICAL CHEMISTRY